Intelligent Subcutaneous Delivery System
Legal Citation
Summary of the Inventive Concept
An advanced, wearable, AI-driven system for personalized subcutaneous medical device implantation, leveraging real-time MRI feedback, bio-absorbable materials, and MEMS-based sensors for optimal tissue health monitoring and minimally invasive procedures.
Background and Problem Solved
The original subcutaneous delivery tool patent, while effective, has limitations in terms of manual operation, limited visualization, and lack of real-time feedback. The new inventive concept addresses these limitations by integrating AI, robotics, and advanced sensing technologies to provide a more efficient, accurate, and patient-centric implantation experience.
Detailed Description of the Inventive Concept
The Intelligent Subcutaneous Delivery System consists of a wearable device featuring an AI-powered core that learns a patient's physiological patterns to optimize personalized medical device implantation. The system incorporates a robotic arm that autonomously navigates to a target implantation site based on real-time MRI feedback, ensuring precise placement and minimizing tissue damage. The implantation tool features a bio-absorbable, shape-memory alloy needle that changes shape in response to body temperature, facilitating minimally invasive implantation. Additionally, the system includes a neural network-based analytics platform that detects potential complications and provides personalized recommendations for correction. An integrated, MEMS-based sensor continuously monitors tissue health and adjusts implantation parameters accordingly.
Novelty and Inventive Step
The new inventive concept introduces the use of AI, robotics, and advanced sensing technologies to revolutionize subcutaneous medical device implantation. The integration of these technologies provides a paradigm shift in the field, enabling more accurate, efficient, and patient-centric implantation procedures. The use of bio-absorbable materials, shape-memory alloy needles, and MEMS-based sensors further enhances the system's novelty and inventive step.
Alternative Embodiments and Variations
Alternative embodiments of the Intelligent Subcutaneous Delivery System could include variations in the wearable device design, such as a handheld or stationary configuration. The AI-powered core could be adapted for use in other medical applications, such as surgical robotics or diagnostic imaging. The system could also be modified to accommodate different types of medical devices or implantation sites.
Potential Commercial Applications and Market
The Intelligent Subcutaneous Delivery System has significant commercial potential in the medical device industry, particularly in the areas of diabetes management, cardiovascular disease treatment, and neurological disorder therapy. The system's ability to provide personalized, minimally invasive implantation procedures could revolutionize the way medical devices are implanted, leading to improved patient outcomes, reduced healthcare costs, and increased market share for companies adopting this technology.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61B17/3468 |
| A | A61 | A61B5/29 |
| A | A61 | A61B17/32093 |
| A | A61 | A61B2017/320044 |
| A | A61 | A61B2017/320056 |
| A | A61 | A61N1/3756 |
| A | A61 | A61N1/37205 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device implantation technologies, specifically subcutaneous monitoring and delivery systems, involving biomedical engineering, robotics, sensor technologies, and minimally invasive medical procedures
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device designer with advanced degrees, expertise in robotic surgical technologies, sensor integration, and understanding of subcutaneous implantation techniques, familiar with AI and machine learning applications in medical device design
Obviousness Rationale
A PHOSITA would recognize that the PTD's AI-driven, robotic subcutaneous delivery system represents a predictable technological evolution of existing implantation tools, applying known machine learning and robotics techniques to enhance precision and personalization of medical device placement. The core technical elements - subcutaneous implantation, visualization, and precise device positioning - are fundamentally consistent with the source patent's teachings, with the PTD primarily introducing incremental technological improvements using standard engineering approaches.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,218 |
|---|---|
| Title | Subcutaneous delivery tool |
| Assignee(s) | Medtronic, Inc. |